Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 15:12:e51178.
doi: 10.2196/51178.

Effectiveness of a Health Education Program for Patients Who Had a Stroke and Their Caregivers by Controlling Modifiable Risk Factors to Reduce Stroke Recurrence in a Tertiary Hospital in Bangladesh: Protocol for a Randomized Controlled Trial

Affiliations

Effectiveness of a Health Education Program for Patients Who Had a Stroke and Their Caregivers by Controlling Modifiable Risk Factors to Reduce Stroke Recurrence in a Tertiary Hospital in Bangladesh: Protocol for a Randomized Controlled Trial

Mahabuba Afrin et al. JMIR Res Protoc. .

Abstract

Background: Stroke is a significant public health concern that causes severe and long-lasting disability. The recurrence of stroke is increasing due to lack of patients' knowledge and compliance with treatment to control modifiable risk factors and lifestyle changes. Health education can be an effective way to increase knowledge about behavioral changes in patients who had a stroke.

Objective: The aim of this study is to evaluate the effectiveness of a health education program in Bangladesh for patients who had their first stroke and their family caregivers in order to reduce the recurrence of stroke by controlling modifiable risk factors.

Methods: This is a parallel, open-label, prospective randomized controlled trial conducted at the National Institute of Neurosciences & Hospital in Dhaka, Bangladesh. We enrolled ≥18-year-old patients of both sexes who had a history of first stroke attack (transient ischemic attack, hemorrhagic stroke, lacunar stroke, atherothrombotic stroke, or cardioembolic stroke). We stratified patients into those aged <65 years and those aged ≥65 years and according to types of strokes for randomization. Our estimated sample size was 432. The intervention group receives face-to-face counseling on lifestyle modifications, blood pressure monitoring, and medication compliance-related health education during enrollment and monthly follow-ups. However, the control group receives only usual care from the hospital. The primary end point of this study is the reduction in the stroke recurrence rates at the end of the 12-month follow-up period. The secondary end points are to (1) assess the occurrence of all adverse events such as other cardiac events and all-cause mortality, (2) evaluate the status of the controlling modifiable risk factors such as blood pressure, glycated hemoglobin, and non-high-density lipoprotein cholesterol, (3) assess the knowledge related to stroke by using the investigator-developed questionnaire, (4) evaluate the lifestyle behavior related to stroke by using the investigator-developed questionnaire, (5) assess medication adherence, and (6) evaluate the quality of life of patients who had a stroke and their family caregivers. The evaluation points will be at baseline, 6 months, and 12 months for both groups.

Results: Patients' enrollment started on October 2022, and follow-up will be completed in March 2024. A total of 432 participants were included in both the intervention (n=216) and control groups (n=216). This study was approved by the institutional review board and the ethics review board of the National Institute of Neurosciences & Hospital (IRB/NINSH/2022/151) on August 30, 2022.

Conclusions: Our health education program is expected to reduce the recurrence of stroke and improve the quality of life of patients who have had the first stroke. The results of this study will provide insights into the importance of health education for (self)-management and prevention of stroke.

Trial registration: ClinicalTrials.gov NCT05520034; https://clinicaltrials.gov/ct2/show/NCT05520034.

International registered report identifier (irrid): DERR1-10.2196/51178.

Keywords: Bangladesh; behavioral change; caregiver; disability; health education; hospital; lifestyle change; modifiable risk factor; quality of life; recurrence; recurrence of stroke; risk factor; stroke; tertiary.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1
Figure 1
Conceptual framwork.
Figure 2
Figure 2
CONSORT (Consolidated Standards of Reporting Trials) chart.
Figure 3
Figure 3
Follow-up and evaluation timeline (months) of the intervention and control groups.

Similar articles

Cited by

References

    1. The top 10 causes of death. World Health Organization 2023. [2023-05-12]. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death .
    1. GBD 2019 Stroke Collaborators Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021 Oct;20(10):795–820. doi: 10.1016/S1474-4422(21)00252-0. https://air.unimi.it/handle/2434/866438 S1474-4422(21)00252-0 - DOI - PMC - PubMed
    1. Kalavina R, Chisati E, Mlenzana N, Wazakili M. The challenges and experiences of stroke patients and their spouses in Blantyre, Malawi. Malawi Med J. 2019 Jun;31(2):112–117. doi: 10.4314/mmj.v31i2.2. https://europepmc.org/abstract/MED/31452843 - DOI - PMC - PubMed
    1. Mondal MBA, Hasan ATMH, Khan N, Mohammad QD. Prevalence and risk factors of stroke in Bangladesh: A nationwide population-based survey. eNeurologicalSci. 2022 Sep;28:100414. doi: 10.1016/j.ensci.2022.100414. https://linkinghub.elsevier.com/retrieve/pii/S2405-6502(22)00023-5 S2405-6502(22)00023-5 - DOI - PMC - PubMed
    1. Owolabi MO, Ugoya S, Platz T. Racial disparity in stroke risk factors: the Berlin-Ibadan experience; a retrospective study. Acta Neurol Scand. 2009 Feb;119(2):81–7. doi: 10.1111/j.1600-0404.2008.01077.x.ANE1077 - DOI - PubMed

Associated data